Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
about
Nebulised surfactant in preterm infants with or at risk of respiratory distress syndromeSurfactant for pulmonary haemorrhage in neonatesIntratracheal Clara cell secretory protein (CCSP) administration in preterm infants with or at risk of respiratory distress syndromeLaryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndromePharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndromeIntra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newbornsAnimal derived surfactant extract for treatment of respiratory distress syndromeEarly surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndromeLong versus short inspiratory times in neonates receiving mechanical ventilationThe use of surfactant in the neonatal period- the known aspects, those still under research and those which need to be investigated furtherGlobal report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions.Do practicing clinicians agree with expert ratings of neonatal intensive care unit quality measures?Early CPAP versus surfactant in extremely preterm infants.Proteomic analysis of amniotic fluid to identify women with preterm labor and intra-amniotic inflammation/infection: the use of a novel computational method to analyze mass spectrometric profilingEarly respiratory management of respiratory distress syndrome in very preterm infants and bronchopulmonary dysplasia: a case-control study.Periostin downregulation is an early marker of inhibited neonatal murine lung alveolar septationClinical benefits, costs, and cost-effectiveness of neonatal intensive care in Mexico.Surfactant use for premature infants with respiratory distress syndrome in three New York city hospitals: discordance of practice from a community clinician consensus standard.The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants.Very Preterm Infants Failing CPAP Show Signs of Fatigue Immediately after BirthImpact of implementing 5 potentially better respiratory practices on neonatal outcomes and costs.The role of surfactant in respiratory distress syndromeBalancing the risks and benefits of oxygen therapy in critically III adults.Surfactant therapy: the current practice and the future trends.Collaborative quality improvement to promote evidence based surfactant for preterm infants: a cluster randomised trial.Application of continuous positive airway pressure in the delivery room: a multicenter randomized clinical trial.Delivery Room Quality Improvement Project Improved Compliance with Best Practices for a Community NICU.Rapid test for lung maturity, based on spectroscopy of gastric aspirate, predicted respiratory distress syndrome with high sensitivity.Update of minimally invasive surfactant therapy.To intubate or not--that is the question: continuous positive airway pressure versus surfactant and extremely low birthweight infants.Des recommandations pour le traitement néonatal par surfactant exogène – Addenda.Recommendations for neonatal surfactant therapy – addendum.
P2860
Q24198153-B41FC3AB-33E9-4999-B8AE-3A77439DF9FAQ24201963-57116D39-30FD-431F-9FAF-04ED7F98A33AQ24234404-166B400D-6EE7-4750-A494-6C3E693C4ED6Q24235572-89A425C9-1137-46D5-80A1-E5816DD6DB8BQ24235658-22A51796-D620-4F66-BE59-61F4C63387DFQ24240793-2C80370E-0B52-4594-8F37-33CD8C7B4218Q24241741-B7063AF0-4241-4353-91E6-FE6F9F5FA38DQ24243075-C9D993F8-E396-4A21-B884-09183059594EQ24247753-F8BE72D8-8FD0-4278-9A3E-9899EA2BF0B8Q26864160-97A565FE-03DE-4980-9E67-101BA6A925BEQ30227236-3F153821-BEF5-480F-92A9-6F3ADE8A53AFQ30414217-8F8CB971-F8FA-4224-876C-3DAF9B557669Q30432764-D170C99E-F421-422B-AB90-F97926D1D1EEQ30484179-E63F2504-CED3-4372-9B78-F01F1EE7DF71Q33272543-ABAD437B-6EEF-425C-A412-A0A65BD60E5EQ33612979-D68410E6-CAE1-43B2-990E-F9468ECA0A9DQ33778610-D7AAD91D-D34D-4BD9-BAAD-26B8ED72DD7CQ33925252-766D8BD4-1CD5-4837-A04E-5228FC8196F1Q34538793-D5D34A04-4C03-4D5A-ABB1-35A14AA5ADFDQ34699188-69DDB501-2020-4F2F-9C5C-B4115DEE87E1Q35656180-8FF915E1-B5BE-4C75-82F5-B01927ABDD4BQ36071266-5FBDD4FE-9AE4-4FEF-95C9-DD9B9FF9F9A6Q36131235-DE9DB89E-92DF-432F-8B8B-B96ABAD7E7F7Q36740778-88E067E4-054F-4E7C-85C6-96A5DAFCB2D9Q37106212-B6F6EF6A-7824-420B-9676-9023F03AF0F1Q37594315-0C001BC1-3870-4250-8CE4-D39EAB600B0CQ37696802-26EA45C1-AE37-44D5-8E17-5255CA6C2695Q39169343-397A91EE-8C25-4122-B29A-3F685B5864C4Q42320091-8CAC3667-A3D4-4141-A869-66F1C385A54FQ42376024-60C77B1E-1970-4C82-9F64-0DFB611B3CEDQ43141829-B81815E0-2E8B-45C6-AAB8-3ADF7BFCA597Q46033535-9B19FA0B-C819-4159-9FB2-9686F9FEB826Q46733104-3A3CA0EF-B67E-41A1-8CCC-340D70C3045D
P2860
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Early versus delayed selective ...... respiratory distress syndrome.
@ast
Early versus delayed selective ...... respiratory distress syndrome.
@en
type
label
Early versus delayed selective ...... respiratory distress syndrome.
@ast
Early versus delayed selective ...... respiratory distress syndrome.
@en
prefLabel
Early versus delayed selective ...... respiratory distress syndrome.
@ast
Early versus delayed selective ...... respiratory distress syndrome.
@en
P1476
Early versus delayed selective ...... respiratory distress syndrome.
@en
P2093
P2860
P304
P356
10.1002/14651858.CD001456
P577
2000-01-01T00:00:00Z